75N95022F00004

KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number: 75N95022F00004
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Other
Title: KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
Source: USASpending (Federal)
Source ID: usa-75N95022F00004

Details

Location: United States

Description

KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4). Awarded to: THE EMMES COMPANY, LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication: 2022/09/28 12:00:00 AM UTC
Closing date: 2027/03/31 12:00:00 AM UTC

Estimated value

$2.1M USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-09-02, 11:57:48 a.m.

Data refreshed every 2 hours